Evidence for common binding of acetaminophen and bromobenzene to the 58-kDa acetaminophen-binding protein

J Toxicol Environ Health. 1995 Nov;46(3):263-9. doi: 10.1080/15287399509532034.

Abstract

Acetaminophen (APAP) toxicity has been closely associated with covalent binding to a cytosolic protein of approximately 58 kDa (58-ABP). To determine if metabolites of other toxicants might also selectively target this protein, studies were conducted with bromobenzene (BrB). Mice were given phenobarbital (80 mg/kg/d x 4 d) and were killed 4 h after challenge with 800 mg BrB/kg. Liver cytosols from BrB-treated or naive mice were incubated with an APAP activating system. Cytosolic fractions were analyzed for APAP binding by Western blotting with anti-APAP antibody. Binding to 58-ABP was selectively decreased in liver cytosol from BrB-treated mice while binding to other targets was minimally affected. Western blotting of the same samples with anti-58-ABP antisera showed that this decrease in binding did not result from diminished 58-ABP content. HPLC analysis of APAP-N-acetyl cysteine conjugate formation in vitro indicates that APAP activation was not altered in the incubates with cytosol from BrB-treated mice. These results suggest that the 58-ABP may be a common target for electrophiles in reactive intermediate toxicity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetaminophen / metabolism*
  • Animals
  • Bromobenzenes / administration & dosage
  • Bromobenzenes / metabolism*
  • Carrier Proteins / metabolism*
  • Liver / metabolism*
  • Male
  • Mice
  • Mice, Inbred ICR
  • Molecular Weight
  • Selenium-Binding Proteins

Substances

  • Bromobenzenes
  • Carrier Proteins
  • Selenbp2 protein, mouse
  • Selenium-Binding Proteins
  • Acetaminophen
  • bromobenzene